CA
BIVV

Commerzbank Aktiengesellschaft’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,613
Closed -$626K – 1046
2017
Q4 		$626K Buy
11,613
+1,773
+18% +$97K 0.01% 623
2017
Q3 		$562K Sell
9,840
-6,018
-38% -$352K 0.01% 582
2017
Q2 		$954K Buy
15,858
+1,607
+11% +$91.5K 0.02% 424
2017
Q1 		$776K Buy
+14,251
New +$702K 0.01% 532

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Commerzbank Aktiengesellschaft's BIVV Position: Q1 2018 in Review

Commerzbank Aktiengesellschaft sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 11,613 shares — an estimated $626K sold.

Commerzbank Aktiengesellschaft first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $954K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Commerzbank Aktiengesellschaft reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 11,613 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $626K.
  • Commerzbank Aktiengesellschaft first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Commerzbank Aktiengesellschaft's Bioverativ Inc. Common Stock position peaked at $954K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2018, filed 1 May 2018.